Subclinical atherosclerosis and subsequent cognitive function.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 25957568)

Published in Atherosclerosis on April 30, 2015

Authors

Heidi C Rossetti1, Myron Weiner2, Linda S Hynan3, C Munro Cullum4, Amit Khera5, Laura H Lacritz4

Author Affiliations

1: Department of Psychiatry, UT Southwestern Medical Center, USA. Electronic address: heidi.rossetti@utsouthwestern.edu.
2: Department of Psychiatry, UT Southwestern Medical Center, USA.
3: Department of Psychiatry, UT Southwestern Medical Center, USA; Department of Clinical Science, UT Southwestern Medical Center, USA.
4: Department of Psychiatry, UT Southwestern Medical Center, USA; Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, USA.
5: Internal Medicine, UT Southwestern Medical Center, USA.

Articles cited by this

"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA (2001) 118.65

Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol (1990) 28.97

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc (2005) 27.90

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA (1997) 17.88

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science (1988) 13.54

The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol (2004) 9.43

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet (1997) 5.04

Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology (2001) 4.78

Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med (2004) 3.66

Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics (1988) 3.20

Vascular risk factors and dementia: how to move forward? Neurology (2009) 2.97

Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation (2003) 2.70

Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol (2006) 2.62

Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology (2011) 2.43

Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr (2000) 2.31

African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study. J Am Coll Cardiol (2004) 2.16

Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord (2004) 2.12

A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. Mov Disord (2008) 1.98

The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet (1991) 1.88

Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology (2011) 1.77

Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study. Stroke (2009) 1.66

Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology (2011) 1.49

Coronary artery calcium, brain function and structure: the AGES-Reykjavik Study. Stroke (2010) 1.45

Cardiovascular disease and cognitive performance in middle-aged and elderly men. Atherosclerosis (2006) 1.40

Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study. Arterioscler Thromb Vasc Biol (2002) 1.38

Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study. Circulation (1996) 1.36

Using MRI to assess aortic wall thickness in the multiethnic study of atherosclerosis: distribution by race, sex, and age. AJR Am J Roentgenol (2004) 1.34

Reduced neuropsychological test performance in asymptomatic carotid stenosis: The Tromsø Study. Neurology (2004) 1.32

Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis (2001) 1.29

Abdominal aortic atherosclerosis at MR imaging is associated with cardiovascular events: the Dallas heart study. Radiology (2013) 1.25

Diabetes and cognitive function in a middle-aged cohort: findings from the Whitehall II study. Neurology (2005) 1.23

Coronary artery calcium: associations with brain magnetic resonance imaging abnormalities and cognitive status. J Am Geriatr Soc (2005) 1.18

Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study. Arterioscler Thromb Vasc Biol (2005) 1.06

Carotid- intima media thickness is independently associated with cognitive decline. The INVADE study. Int J Geriatr Psychiatry (2010) 1.04

A review of carotid atherosclerosis and vascular cognitive decline: a new understanding of the keys to symptomology. Neurosurgery (2010) 1.04

Carotid atherosclerosis and 10-year changes in cognitive function. Atherosclerosis (2012) 1.02

Carotid atherosclerosis predicts lower cognitive test results: a 7-year follow-up study of 4,371 stroke-free subjects - the Tromsø study. Cerebrovasc Dis (2012) 1.02

Adventitial vasa vasorum heterogeneity among different vascular beds. J Vasc Surg (2004) 1.00

Psychometric evaluation of the Montreal Cognitive Assessment (MoCA) in three diverse samples. Clin Neuropsychol (2010) 0.99

Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults. Stroke (2012) 0.97

Atherosclerotic calcification relates to cognitive function and to brain changes on magnetic resonance imaging. Alzheimers Dement (2012) 0.95

Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease. Neurobiol Aging (2008) 0.94

Carotid atherosclerosis and prospective risk of dementia. Stroke (2012) 0.93

Subclinical atherosclerotic calcification and cognitive functioning in middle-aged adults: the CARDIA study. Atherosclerosis (2013) 0.89

Subclinical atherosclerosis is weakly associated with lower cognitive function in healthy hyperhomocysteinemic adults without clinical cardiovascular disease. Int J Geriatr Psychiatry (2009) 0.87

Measurement of aortic intimal-medial thickness in adolescents and young adults. Ultrasound Med Biol (2010) 0.86

CT imaging of coronary artery calcium as an indicator of atherosclerotic disease: an overview. J Thorac Imaging (2001) 0.84

Carotid artery plaque progression and cognitive decline: the Tromsø Study 1994-2008. Eur J Neurol (2012) 0.80

Lack of association between apolipoprotein E genotypes and cognitive performance in the non-demented elderly. Psychogeriatrics (2013) 0.76